Table 1.
Site profile, WHO RSV surveillance, 2017‐19
| Country | Duration of surveillance | No. of sentinel sites | Patients under surveillance | Number of clinical samples considered for analysis |
|---|---|---|---|---|
| Argentina | 2017 Week 1‐2019 Week 14 | 6 | Inpatient | 1660 |
| Australia | 2017 Week 31‐ 2019 Week 17 | 1 | Inpatient | 2005 |
| Brazil | 2017 Week 3‐2019 Week 7 | 2 | Inpatient + outpatient | 756 |
| Canada | 2017 Week 44‐2018 Week 22; and 2018 Week 44‐2019 Week 22 | 12 | Inpatient | 4892 |
| Chile | 2017 Week 1‐2019 Week 13 | 2 | Inpatient | 1134 |
| Côte d’Ivoire | 2017 Week 1‐2019 Week 1 | 9 | Inpatient + outpatient | 3362 |
| Egypt | 2017 Week 1‐2019 Week 14 | 6 | Inpatient | 1688 |
| India | 2017 Week 1‐2019 Week 9 | 11 | Inpatient + outpatient | 1998 |
| Mongolia | 2017 Week 2‐2019 Week 15 | 7 | Inpatient + outpatient | 1803 |
| Mozambique | 2017 Week 1‐2019 Week 3 | 4 | Inpatient + outpatient | 1329 |
| Russian Federation | 2017 Week 1‐2019 Week 15 | 18 | Inpatient | 2067 |
| South Africa | 2017 Week 1‐2019 Week 18 | 5 | Inpatient | 6002 |
| Thailand | 2017 Week 1‐2019 Week 5 | 11 | Inpatient + outpatient | 3106 |
| United Kingdoma | 2017 Week 39‐2019 Week 12 | 70 GP | Outpatient | 4250 |
Abbreviation: GP, General practitioners.
a
Surveillance restricted to England only.